Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Other Accumulated Expenses (2020 - 2026)

Updated

Vivos Therapeutics' Other Accumulated Expenses was $1.2 million in Q2 2026, up 18.2% from $1.02 million a year earlier but down 2.8% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Vivos Therapeutics came in at $850,000, up 76.7% from FY2024.

  • Other Accumulated Expenses has now increased for three consecutive years, though with a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $481,000 in FY2024 (+47.1%), $327,000 in FY2023 (+125.5%) and $145,000 in FY2022.
  • Quarterly Other Accumulated Expenses has moved between $127,000 (Q1 2023) and $1.23 million (Q1 2026) over five years.
  • Compared with a year earlier, Other Accumulated Expenses has increased for seven straight quarters, with growth averaging 170.5% over the last eight quarters.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2025 (growth of 572.2%); the worst was Q2 2023 (a decline of 55.7%).
  • Per Business Quant data, VVOS's Other Accumulated Expenses in the three quarters before Q2 2026 was $1.23 million (Q1 2026), $850,000 (Q4 2025) and $987,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 1.23 Mn
Dec 31, 2025 850,000.00
Sep 30, 2025 987,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 672,000.00
Dec 31, 2024 481,000.00
Sep 30, 2024 199,000.00
Jun 30, 2024 151,000.00
Mar 31, 2024 224,000.00
Dec 31, 2023 327,000.00
Sep 30, 2023 284,000.00
Jun 30, 2023 160,000.00
Mar 31, 2023 127,000.00
Dec 31, 2022 145,000.00
Sep 30, 2022 294,000.00
Jun 30, 2022 361,000.00
Dec 31, 2020 1.50 Mn
API Access

Vivos Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VVOS&period=max&api_key=YOUR_API_KEY